Rita Mazza

851 total citations
22 papers, 298 citations indexed

About

Rita Mazza is a scholar working on Pathology and Forensic Medicine, Oncology and Hematology. According to data from OpenAlex, Rita Mazza has authored 22 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 8 papers in Oncology and 7 papers in Hematology. Recurrent topics in Rita Mazza's work include Lymphoma Diagnosis and Treatment (12 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Rita Mazza is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Rita Mazza collaborates with scholars based in Italy, Switzerland and Ukraine. Rita Mazza's co-authors include Luca Castagna, Armando Santoro, Antonella Anastasia, Laura Giordano, Barbara Sarina, Carmelo Carlo‐Stella, Stéfania Bramanti, Elisabetta Todisco, Monica Balzarotti and Massimo Magagnoli and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Rita Mazza

18 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rita Mazza Italy 12 216 178 109 71 64 22 298
Antonella Anastasia Italy 10 216 1.0× 161 0.9× 92 0.8× 78 1.1× 30 0.5× 21 284
Anna Ruskova New Zealand 8 184 0.9× 97 0.5× 86 0.8× 93 1.3× 53 0.8× 15 282
Joël Fleury France 6 198 0.9× 168 0.9× 98 0.9× 62 0.9× 93 1.5× 7 315
Lucille Baseggio France 4 276 1.3× 137 0.8× 75 0.7× 169 2.4× 34 0.5× 9 315
Akash Nahar United States 7 255 1.2× 306 1.7× 91 0.8× 59 0.8× 29 0.5× 32 384
Max Beijert Netherlands 7 194 0.9× 72 0.4× 181 1.7× 137 1.9× 41 0.6× 17 283
Alessandra Cuttica Italy 8 204 0.9× 147 0.8× 47 0.4× 80 1.1× 87 1.4× 10 287
Marita Kloess Germany 7 265 1.2× 136 0.8× 189 1.7× 121 1.7× 21 0.3× 12 348
Gaetana Capobianco Italy 10 198 0.9× 134 0.8× 68 0.6× 90 1.3× 15 0.2× 21 281
Ulrich von Gruenhagen Germany 10 421 1.9× 266 1.5× 80 0.7× 289 4.1× 41 0.6× 11 458

Countries citing papers authored by Rita Mazza

Since Specialization
Citations

This map shows the geographic impact of Rita Mazza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita Mazza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita Mazza more than expected).

Fields of papers citing papers by Rita Mazza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita Mazza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita Mazza. The network helps show where Rita Mazza may publish in the future.

Co-authorship network of co-authors of Rita Mazza

This figure shows the co-authorship network connecting the top 25 collaborators of Rita Mazza. A scholar is included among the top collaborators of Rita Mazza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita Mazza. Rita Mazza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Godino, Cosmo, Rita Mazza, Anna Salerno, et al.. (2025). Plasma levels measurement of the 4 direct oral anticoagulants in patients with atrial fibrillation at the time of acute thromboembolic and bleeding events. Journal of Thrombosis and Haemostasis. 23(11). 3515–3526. 1 indexed citations
2.
Gentile, Francesco, Fabrizia Terenghi, Pietro Emiliano Doneddu, et al.. (2023). Regular assessment of serum vascular endothelial growth factor levels to monitor POEMS syndrome. Neurological Sciences. 45(2). 727–733.
3.
Lorenzi, Elena, Lucia Morello, Laura Giordano, et al.. (2022). Quality of life of adult cancer survivors enrolled in Humanitas Research Hospital’s survivorship care model. Supportive Care in Cancer. 30(7). 5561–5564. 1 indexed citations
5.
Trani, Martina Di, Francesca Ricci, Martina Sollini, et al.. (2021). Circulating Tumor DNA Integrated with Interim [18F]FDG PET Is Highly Effective in Predicting Outcome of Relapsed/Refractory Classical Hodgkin Lymphoma Treated with the Begev Regimen. Blood. 138(Supplement 1). 3504–3504. 1 indexed citations
6.
Santoro, Armando, Rita Mazza, Alessandro Pulsoni, et al.. (2020). Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma. Blood Advances. 4(1). 136–140. 22 indexed citations
7.
Mazza, Rita, et al.. (2017). Acute promyelocytic leukemia with a cryptic insertion of RARA into PML on chromosome 15 due to uniparental isodisomy: A case report. Oncology Letters. 13(6). 4180–4184. 2 indexed citations
9.
Castagna, Luca, Carmelo Carlo‐Stella, Rita Mazza, & Armando Santoro. (2015). CURRENT ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA. Mediterranean Journal of Hematology and Infectious Diseases. 7(1). e2015015–e2015015. 14 indexed citations
10.
Carlo‐Stella, Carmelo, Francesca Ricci, Rita Mazza, et al.. (2015). Brentuximab Vedotin in Patients With Hodgkin Lymphoma and a Failed Allogeneic Stem Cell Transplantation: Results From a Named Patient Program at Four Italian Centers. The Oncologist. 20(3). 323–328. 25 indexed citations
12.
13.
Castagna, Luca, Stéfania Bramanti, Alessandro Levis, et al.. (2009). Pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous peripheral blood stem cell support. Annals of Oncology. 21(7). 1482–1485. 16 indexed citations
14.
Castagna, Luca, Stéfania Bramanti, Monica Balzarotti, et al.. (2009). Predictive value of early 18F‐fluorodeoxyglucose positron emission tomography (FDG‐PET) during salvage chemotherapy in relapsing/refractory Hodgkin lymphoma (HL) treated with high‐dose chemotherapy. British Journal of Haematology. 145(3). 369–372. 38 indexed citations
15.
Anastasia, Antonella, Fabio Giglio, Rita Mazza, et al.. (2009). Early discharge after high-dose melphalan and peripheral blood stem cell reinfusion in patients with hematological and non-hematological disease. Leukemia & lymphoma. 50(1). 80–84. 13 indexed citations
16.
Castagna, Luca, Barbara Sarina, Elisabetta Todisco, et al.. (2009). Allogeneic Stem Cell Transplantation Compared with Chemotherapy for Poor-Risk Hodgkin Lymphoma. Biology of Blood and Marrow Transplantation. 15(4). 432–438. 18 indexed citations
17.
Todisco, Elisabetta, Luca Castagna, Barbara Sarina, et al.. (2007). Reduced‐intensity allogeneic transplantation in patients with refractory or progressive Hodgkin's disease after high‐dose chemotherapy and autologous stem cell infusion. European Journal Of Haematology. 78(4). 322–329. 15 indexed citations
18.
Todisco, Elisabetta, Luca Castagna, Barbara Sarina, et al.. (2007). CD34+ dose‐driven administration of granulocyte colony‐stimulating factor after high‐dose chemotherapy in lymphoma patients. European Journal Of Haematology. 78(2). 111–116. 4 indexed citations
19.
Castagna, Luca, Massimo Magagnoli, Monica Balzarotti, et al.. (2006). Tandem high‐dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: A monocenter prospective study. American Journal of Hematology. 82(2). 122–127. 22 indexed citations
20.
Radaelli, Franca, et al.. (2002). Acute megakaryocytic leukemia in essential thrombocythemia: an unusual evolution?. European Journal Of Haematology. 69(2). 108–111. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026